European Journal of Clinical Pharmacology

, Volume 69, Issue 3, pp 565–571

Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care

  • M. L. Andersson
  • Y. Böttiger
  • J. D. Lindh
  • B. Wettermark
  • B. Eiermann
Pharmacoepidemiology and Prescription

DOI: 10.1007/s00228-012-1338-y

Cite this article as:
Andersson, M.L., Böttiger, Y., Lindh, J.D. et al. Eur J Clin Pharmacol (2013) 69: 565. doi:10.1007/s00228-012-1338-y

Abstract

Purpose

To investigate the impact of the integration of the drug-drug interaction database SFINX into primary health care records on the prevalence of potentially serious drug-drug interactions.

Methods

The study was a controlled before-and-after study on the prevalence of potential drug-drug interactions before and after the implementation of SFINX at 15 primary healthcare centres compared with 5 centres not receiving the intervention. Data on dispensed prescriptions from health care centres were retrieved from the Swedish prescribed drug register and analysed for September–December 2006 (pre-intervention) and September–December 2007 (post-intervention). All drugs dispensed during each 4 month period were regarded as potentially interacting.

Results

Use of SFINX was associated with a 17% decrease, to 1.81 × 10−3 from 2.15 × 10−3 interactions per prescribed drug-drug pair, in the prevalence of potentially serious drug-drug interactions (p = 0.042), whereas no significant effect was observed in the control group. The change in prevalence of potentially serious drug-drug interactions did not differ significantly between the two study groups. The majority of drug-drug interactions identified were related to chelate formation.

Conclusion

Prescriptions resulting in potentially serious drug-drug interactions were significantly reduced after integration of the drug-drug interaction database SFINX into electronic health records in primary care. Further studies are needed to demonstrate the effectiveness of drug-drug interaction warning systems.

Keywords

Drug-drug interactionsClinical decision support systemsDatabase management systemsMedical order entry systemsMedication errors/prevention and control

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • M. L. Andersson
    • 1
  • Y. Böttiger
    • 1
  • J. D. Lindh
    • 1
  • B. Wettermark
    • 1
    • 2
  • B. Eiermann
    • 1
  1. 1.Department of Laboratory Medicine, Division of Clinical PharmacologyKarolinska University Hospital, Huddinge, Karolinska InstitutetStockholmSweden
  2. 2.Public Healthcare Services CommitteeStockholm County CouncilStockholmSweden